Delve Insight Market Research Reports

TITLE Actions
Kidney Transplant Rejection - Pipeline Insight, 2021
Published in Sep 2021 | US $ 1500 Onwards | By Delve Insight

DelveInsight’s, “Kidney Transplant Rejection – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Kidney Transplant Rejection pipeline landscape. It covers the pipeline drug profiles, includi...

Congenital Adrenal Hyperplasia - Pipeline Insight, 2021
Published in Sep 2021 | US $ 1500 Onwards | By Delve Insight

DelveInsight’s, “Congenital Adrenal Hyperplasia – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Congenital Adrenal Hyperplasia pipeline landscape. It covers the pipeline drug profiles, inc...

Schizoaffective Disorder - Pipeline Insight, 2021
Published in Sep 2021 | US $ 1500 Onwards | By Delve Insight

DelveInsight’s, “Schizoaffective Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Schizoaffective Disorder pipeline landscape. It covers the pipeline drug profiles, including clini...

Major Depressive Disorder - Market Insight, Epidemiology and Market Forecast - 2030
Published in Aug 2021 | US $ 6950 Onwards | By Delve Insight

DelveInsight’s ‘Major Depressive Disorder—Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the Major Depressive Disorder, historical and forecasted epidemiology as well as the market trends in the ...

Human Papillomavirus 16-positive (HPV16+) Cancers - Market Insight, Epidemiology and Market Forecast - 2030
Published in Aug 2021 | US $ 6950 Onwards | By Delve Insight

DelveInsight’s ‘HPV 16+ Cancer– Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the HPV 16+ Cancer, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Ge...

Functional Dyspepsia - Market Insights, Epidemiology, and Market Forecast - 2030
Published in Aug 2021 | US $ 6950 Onwards | By Delve Insight

DelveInsight’s ‘Functional Dyspepsia—Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the Functional Dyspepsia, historical and forecasted epidemiology as well as the market trends in the United Stat...

Anemia Market Insight, Epidemiology and Market Forecast 2030
Published in Aug 2021 | US $ 6950 Onwards | By Delve Insight

DelveInsight’s ‘Iron deficiency anemia (IDA) - Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the IDA, historical and forecasted epidemiology as well as the IDA market trends in the United States,...

Persistent Epithelial Defect - Market Insight, Epidemiology and Market Forecast - 2030
Published in Aug 2021 | US $ 6950 Onwards | By Delve Insight

DelveInsight’s ‘Persistent Epithelial Defect (PED)–Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the Persistent Epithelial Defect (PED), historical and forecasted epidemiology as well as the mark...

ESR1 Mutated Metastatic Breast Cancer - Market Insight, Epidemiology and Market Forecast - 2030
Published in Aug 2021 | US $ 6950 Onwards | By Delve Insight

DelveInsight’s ‘ESR1 Mutated Metastatic Breast Cancer-Market Insights, Epidemiology, and Market Forecast–2030’ report deliver an in-depth understanding of the ESR1 Mutated Metastatic Breast Cancer, historical and forecasted epidemiology as well as th...

Chronic Obstructive Pulmonary Disease (COPD) - Market Insight, Epidemiology and Market Forecast - 2030
Published in Aug 2021 | US $ 9500 Onwards | By Delve Insight

DelveInsight’s ‘Chronic Obstructive Pulmonary Disease (COPD)-Market Insights, Epidemiology, and Market Forecast–2030’ report deliver an in-depth understanding of the Chronic Obstructive Pulmonary Disease (COPD), historical and forecasted epidemiol...

Soft Tissue Sarcoma - Pipeline Insight, 2021
Published in Jul 2021 | US $ 3000 Onwards | By Delve Insight

DelveInsight’s, “Soft Tissue Sarcoma - Pipeline Insight, 2021,” report provides comprehensive insights about 130+ companies and 130+ pipeline drugs in Soft Tissue Sarcoma pipeline landscape. It covers the pipeline drug profiles, including clinical an...

HR+/ HER2-VE Breast Cancer - Pipeline Insight, 2021
Published in Jul 2021 | US $ 2500 Onwards | By Delve Insight

DelveInsight’s, “HR+/ HER2-VE Breast Cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in HR+/ HER2-VE Breast Cancer pipeline landscape. It covers the pipeline drug profiles, including...

Hemophilia A - Pipeline Insight, 2021
Published in Jul 2021 | US $ 2500 Onwards | By Delve Insight

DelveInsight’s, “Hemophilia A - Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 40+ pipeline drugs in Hemophilia A pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st...

Hidradenitis Suppurativa - Pipeline Insight, 2021
Published in Jul 2021 | US $ 2000 Onwards | By Delve Insight

DelveInsight’s, “Hidradenitis Suppurativa - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Hidradenitis Suppurativa pipeline landscape. It covers the pipeline drug profiles, including cli...

Prosthetic joint infections - Pipeline Insight, 2021
Published in Jul 2021 | US $ 1500 Onwards | By Delve Insight

DelveInsight’s, “Prosthetic joint infections - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Prosthetic joint infections pipeline landscape. It covers the pipeline drug profiles, including...

Progressive Supranuclear Palsy - Pipeline Insight, 2021
Published in Jul 2021 | US $ 1500 Onwards | By Delve Insight

DelveInsight’s, “Progressive Supranuclear Palsy - Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Progressive Supranuclear Palsy pipeline landscape. It covers the pipeline drug profiles, i...

Pulmonary Arterial Hypertension - Pipeline Insight, 2021
Published in Jul 2021 | US $ 2500 Onwards | By Delve Insight

DelveInsight’s, “Pulmonary Arterial Hypertension - Pipeline Insight, 2021,” report provides comprehensive insights about 55+ companies and 55+ pipeline drugs in Pulmonary Arterial Hypertension pipeline landscape. It covers the pipeline drug profiles,...

Immune thrombocytopenia - Pipeline Insight, 2021
Published in Jul 2021 | US $ 2000 Onwards | By Delve Insight

DelveInsight’s, “Immune thrombocytopenia - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Immune thrombocytopenia pipeline landscape. It covers the pipeline drug profiles, including clini...

Chronic Pancreatitis - Pipeline Insight, 2021
Published in Jul 2021 | US $ 1500 Onwards | By Delve Insight

DelveInsight’s, “Chronic Pancreatitis - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Chronic Pancreatitis pipeline landscape. It covers the pipeline drug profiles, including clinical and ...

Nonmuscle invasive bladder cancer - Pipeline Insight, 2021
Published in Jul 2021 | US $ 2000 Onwards | By Delve Insight

DelveInsight’s, “Nonmuscle invasive bladder cancer - Pipeline Insight, 2021,” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Nonmuscle invasive bladder cancer pipeline landscape. It covers the pipeline drug profi...

We are on:

Need Help?

Buy Any Report Avail 20% Discount. Coupon Code: DEC20

Connect for special KNOWLEDGE STORE Deals
Subscription starts at $ 20K